Felipe Duran

Felipe Duran has a strong background in finance and strategic planning. Felipe is currently serving as the Interim Chief Financial Officer at iBio, Inc., where they align financial operations with organizational goals and provides insight to the executive team and Board of Directors. Prior to that, Felipe was the Vice President of Financial Planning at iBio, Inc., where they led a restructuring of financial processes and strategies, negotiated financial agreements, and oversaw a critical acquisition.

Before joining iBio, Inc., Felipe worked at Lupin Pharmaceuticals as the Executive Director of Finance for LATAM and United States R&D, as well as the LATAM Chief Financial Officer. In this role, they managed budgets, led commercial excellence programs, and achieved a 50% boost in sales within 5 years.

Additionally, Felipe has experience at Teva Pharmaceuticals, where they served as the Director of Strategic Planning and Associate Director of Strategic Planning. Felipe was responsible for building comprehensive product P&Ls, organizing financial operations across multiple countries, and leading the integration of a major acquisition in the Mexican market.

Felipe Duran obtained an MBA degree in Finance and Management from the University of Miami in 2006-2007. Prior to that, they completed their undergraduate studies at the University of Miami Herbert Business School, earning a B.B.A degree in Finance from 1997 to 2001. Details about their education before university are unavailable.